To assess whether SPARC is differentially expressed in patients with NAFLD, we performed bioinformatic analysis using a public hepatic RNAseq database, GSE130970 [26], which classifies patients at different points of the NAFLD spectrum. The gene discussed is SPARC; the disease is metabolic dysfunction-associated steatotic liver disease.